FDG PET to Diagnose Neurolymphomatosis in a Case of Triple-Hit B-Cell Lymphoma

Clin Nucl Med. 2017 Jun;42(6):458-460. doi: 10.1097/RLU.0000000000001608.

Abstract

A 46-year-old man with stage IV triple-hit B-cell lymphoma diagnosed in February 2016 was treated with chemotherapy. He was followed classically with FDG PET/CT, which assessed the complete metabolic response in June 2016. In July 2016, he had autologous stem cell transplantation. Two months later, he underwent an FDG PET/CT for revaluation. It showed intense FDG uptake in the medullary canal from cervical 4 to thoracic 4, bilateral cervical 7 to thoracic 8, and right thoracic 9 to 12 nerve roots, leading to the diagnosis of neurolymphomatosis. A clinical cervical radiculopathy and spinal MRI results reinforced this diagnosis.

Publication types

  • Case Reports

MeSH terms

  • Animals
  • Fluorodeoxyglucose F18*
  • Humans
  • Lymphoma, B-Cell / complications*
  • Lymphoma, B-Cell / pathology
  • Magnetic Resonance Imaging
  • Male
  • Marek Disease / complications*
  • Marek Disease / diagnostic imaging*
  • Middle Aged
  • Neoplasm Staging
  • Positron Emission Tomography Computed Tomography*

Substances

  • Fluorodeoxyglucose F18